GR76691B - - Google Patents

Info

Publication number
GR76691B
GR76691B GR66793A GR810166793A GR76691B GR 76691 B GR76691 B GR 76691B GR 66793 A GR66793 A GR 66793A GR 810166793 A GR810166793 A GR 810166793A GR 76691 B GR76691 B GR 76691B
Authority
GR
Greece
Application number
GR66793A
Inventor
J Gold Sworthy
W J Ross
J P Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of GR76691B publication Critical patent/GR76691B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR66793A 1980-12-19 1981-12-15 GR76691B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040732 1980-12-19

Publications (1)

Publication Number Publication Date
GR76691B true GR76691B (el) 1984-08-24

Family

ID=10518094

Family Applications (1)

Application Number Title Priority Date Filing Date
GR66793A GR76691B (el) 1980-12-19 1981-12-15

Country Status (10)

Country Link
US (1) US4390541A (el)
EP (1) EP0055068B1 (el)
JP (1) JPS57131766A (el)
CA (1) CA1173445A (el)
DE (1) DE3166737D1 (el)
DK (1) DK565281A (el)
GB (1) GB2089795B (el)
GR (1) GR76691B (el)
HU (1) HU185329B (el)
IL (1) IL64544A (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206146A1 (de) * 1982-02-20 1983-09-01 Vorwerk & Co Interholding Gmbh, 5600 Wuppertal Aerosol-reinigungsmittel
US4478820A (en) * 1982-09-30 1984-10-23 Eli Lilly And Company Anilino-substituted isoquinoline quinones, pharmaceutical compositions and method of use thereof
WO1995023787A1 (fr) * 1994-03-01 1995-09-08 Ishihara Sangyo Kaisha, Ltd. Procede de production de 5,7-dichloro-4-hydroxyquinoleine
FR2783826B1 (fr) * 1998-09-29 2002-07-19 Rhodia Chimie Sa Procede de preparation de 4-hydroxyquinoleines et/ou formes tautomeres
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US7355047B2 (en) * 2002-05-14 2008-04-08 The Regents Of The University Of California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
ES2656017T3 (es) 2004-06-24 2018-02-22 Vertex Pharmaceuticals Incorporated Moduladores de transportadores del casete de unión a ATP
DK3219705T3 (da) 2005-12-28 2020-04-14 Vertex Pharma Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
AU2013226076B2 (en) 2012-02-27 2017-11-16 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR879283A (fr) * 1941-04-03 1943-02-18 Ig Farbenindustrie Ag Procédé pour la production de produits de condensation
GB830832A (en) 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
GB1433774A (en) 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
DE2901336A1 (de) * 1979-01-15 1980-07-24 Boehringer Mannheim Gmbh Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
CA1173445A (en) 1984-08-28
IL64544A (en) 1985-05-31
GB2089795B (en) 1985-05-30
HU185329B (en) 1985-01-28
GB2089795A (en) 1982-06-30
JPS57131766A (en) 1982-08-14
US4390541A (en) 1983-06-28
DE3166737D1 (en) 1984-11-22
EP0055068A1 (en) 1982-06-30
IL64544A0 (en) 1982-03-31
DK565281A (da) 1982-06-20
EP0055068B1 (en) 1984-10-17

Similar Documents

Publication Publication Date Title
FR2473077B1 (el)
FR2475542B1 (el)
FR2473871B1 (el)
FR2473466B1 (el)
FR2473575B1 (el)
FR2473132B1 (el)
FR2473725B1 (el)
FR2475267B1 (el)
FR2474192B1 (el)
FR2473796B1 (el)
DE3115054C2 (el)
FR2474716B1 (el)
FR2475392B1 (el)
FR2474379B3 (el)
IN155673B (el)
DE3153720A1 (el)
FR2473555B1 (el)
FR2475317B1 (el)
FR2473189B1 (el)
FR2475358B3 (el)
FR2473780B1 (el)
FR2473058B1 (el)
FR2473188B1 (el)
FR2473183B1 (el)
FR2474325B3 (el)